Prudential Financial
AXSM icon

Prudential Financial’s Axsome Therapeutics AXSM Stock Holding History

Prudential Financial’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.63M Sell
10,764
-13,809
-56% -$2.99M ﹤0.01% 1288
2026
Q1 		$4.15M Buy
24,573
+19,158
+354% +$3.31M 0.01% 1004
2025
Q4 		$989K Buy
5,415
+357
+7% +$49.8K ﹤0.01% 1597
2025
Q3 		$614K Sell
5,058
-17,750
-78% -$2M ﹤0.01% 1851
2025
Q2 		$2.15M Sell
22,808
-6,605
-22% -$699K ﹤0.01% 1352
2025
Q1 		$3.43M Buy
29,413
+26,740
+1,000% +$3.05M ﹤0.01% 1022
2024
Q4 		$249K Sell
2,673
-27
-1% -$2.48K ﹤0.01% 2039
2024
Q3 		$243K Sell
2,700
-180
-6% -$15.7K ﹤0.01% 2463
2024
Q2 		$232K Buy
2,880
+117
+4% +$8.66K ﹤0.01% 2441
2024
Q1 		$220K Buy
2,763
+38
+1% +$3.19K ﹤0.01% 2442
2023
Q4 		$217K Buy
+2,725
New +$182K ﹤0.01% 2417
2020
Q4 		– Sell
-7,545
Closed -$538K – 2447
2020
Q3 		$538K Sell
7,545
-14,667
-66% -$1.14M ﹤0.01% 1923
2020
Q2 		$1.83M Buy
+22,212
New +$1.71M ﹤0.01% 1378
2020
Q1 		– Sell
-2,520
Closed -$260K – 2354
2019
Q4 		$260K Buy
+2,520
New +$102K ﹤0.01% 2256

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Prudential Financial's AXSM Position: Q2 2026 in Review

Prudential Financial reduced its Axsome Therapeutics (AXSM) stake by 56% in Q2 2026, selling an estimated $2.99M and leaving 10,764 shares worth $2.63M. The position accounts for ﹤0.01% of the portfolio, ranked #1288.

Prudential Financial first reported a position in AXSM in Q4 2019 and has held it in 14 quarters since. The position peaked at $4.15M in Q1 2026. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Prudential Financial held 10,764 shares of Axsome Therapeutics worth $2.63M as of Q2 2026.
  • Prudential Financial sold 13,809 Axsome Therapeutics shares in Q2 2026, an estimated $2.99M.
  • Axsome Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #1288 holding.
  • Prudential Financial first reported a position in Axsome Therapeutics in Q4 2019 and has held it in 14 quarters since.
  • Prudential Financial's Axsome Therapeutics position peaked at $4.15M in Q1 2026.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.